<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 26.7: Measuring Efficacy: Clinical KPIs and Data Interpretation</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Program Development */
        .module-header {
            background: linear-gradient(135deg, #0f172a 0%, #334155 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #334155;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0f172a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #334155;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f9ff;
            border: 2px solid #0ea5e9;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0369a1;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸ“Š';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0f172a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0f2fe 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #0369a1;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: linear-gradient(135deg, #334155 0%, #475569 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background-color: #f1f5f9;
            color: #334155;
            font-weight: 600;
            padding: 15px;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Stats Box */
        .stat-highlight {
            background: #f0f9ff;
            padding: 4px 8px;
            border-radius: 4px;
            color: #0369a1;
            font-weight: 700;
            font-family: 'Courier New', Courier, monospace;
        }

        /* Check Understanding */
        .check-understanding {
            background: #f8fafc;
            border: 2px solid #cbd5e1;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e2e8f0;
        }

        .reveal-btn {
            background: #334155;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f1f5f9;
            border-radius: 8px;
            border-left: 4px solid #334155;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: #1e293b;
            color: #f1f5f9;
            padding: 30px 35px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            color: #38bdf8;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 2px;
            font-size: 13px;
            margin-bottom: 20px;
            display: block;
        }

        .takeaways-box ul {
            margin: 0;
            padding-left: 20px;
        }

        .takeaways-box li {
            margin-bottom: 12px;
        }

        /* References Box */
        .references-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 12px;
            margin-top: 60px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            font-size: 16px;
            color: #4b5563;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .references-box li {
            font-size: 13px;
            color: #6b7280;
            margin-bottom: 8px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 26: Program Development & Strategic Growth</p>
            <h1 class="lesson-title">Lesson 7: Measuring Efficacy: Clinical KPIs and Data Interpretation</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Advanced Practitioner Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#kpi-selection"><span class="section-num">1</span>The 'Vital Few' KPIs</a></li>
                <li><a href="#lab-interpretation"><span class="section-num">2</span>Interpreting Follow-up Testing</a></li>
                <li><a href="#symptom-lab-gap"><span class="section-num">3</span>Managing the Symptom-Lab Gap</a></li>
                <li><a href="#digital-tracking"><span class="section-num">4</span>Wearables & Real-Time Feedback</a></li>
                <li><a href="#documentation"><span class="section-num">5</span>Creating Success Case Files</a></li>
                <li><a href="#pivot-points"><span class="section-num">6</span>Clinical Decision Pivot Points</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Identify the specific Key Performance Indicators (KPIs) relevant to each of the four stages of the C.A.L.M. Autoimmune Protocolâ„¢.</li>
                <li>Quantify the clinical significance of biomarker shifts, including antibody titers and inflammatory markers.</li>
                <li>Develop strategies for reconcile discordant data when laboratory results and clinical symptoms do not align.</li>
                <li>Integrate digital health tracking data (HRV, sleep, glucose) into a cohesive autoimmune management plan.</li>
                <li>Synthesize client data into "Success Case Files" for professional collaboration and practice growth.</li>
            </ul>
        </div>

        <h2 id="kpi-selection">1. Selecting the 'Vital Few' KPIs</h2>
        <p>In the management of complex autoimmune conditions, the sheer volume of data can be overwhelming. As an Autoimmune Specialist, your role is to filter the noise and focus on the <span class="highlight">"Vital Few" Key Performance Indicators (KPIs)</span>. These are the metrics that provide the highest signal-to-noise ratio regarding the efficacy of your intervention.</p>
        
        <p>Efficacy measurement must be mapped directly to the <strong>C.A.L.M. Autoimmune Protocolâ„¢</strong> framework. A metric that is vital in the "Contain" phase may be secondary during the "Maintain" phase. A 2021 study in the <i>Journal of Personalized Medicine</i> emphasized that personalized health monitoring reduces flare frequency by <span class="stat-highlight">34%</span> when practitioners focus on dynamic rather than static markers.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>C.A.L.M. Phase</th>
                        <th>Primary KPI Focus</th>
                        <th>Clinical Rationale</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>C: Contain</strong></td>
                        <td>hs-CRP, ESR, Subjective Pain Score (VAS), Sleep Latency</td>
                        <td>Measuring the immediate reduction of systemic inflammatory load and acute symptom burden.</td>
                    </tr>
                    <tr>
                        <td><strong>A: Address</strong></td>
                        <td>Specific Antibody Titers (TPO, ANA), Zonulin, Microbiome Diversity</td>
                        <td>Validating that root cause interventions (gut repair, pathogen clearance) are modulating the immune response.</td>
                    </tr>
                    <tr>
                        <td><strong>L: Lifestyle</strong></td>
                        <td>Heart Rate Variability (HRV), Cortisol Awakening Response (CAR), Step Count</td>
                        <td>Assessing the resilience of the Neuro-Endocrine-Immune (NEI) axis and mitochondrial capacity.</td>
                    </tr>
                    <tr>
                        <td><strong>M: Maintain</strong></td>
                        <td>Food Reintroduction Tolerance, Flare Recovery Time, Quality of Life (QoL) Index</td>
                        <td>Measuring long-term stability and the client's ability to maintain remission in the "real world."</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="lab-interpretation">2. Interpreting Follow-up Functional Testing</h2>
        <p>A common mistake in autoimmune coaching is the misinterpretation of follow-up laboratory data. We often look for "normal" ranges, but in autoimmunity, we are looking for <span class="highlight">velocity and trajectory</span>. For example, if a clientâ€™s Thyroid Peroxidase (TPO) antibodies drop from 800 IU/mL to 600 IU/mL, they are still technically "high," but the <span class="stat-highlight">25% reduction</span> represents a significant dampening of the autoimmune attack.</p>

        <p>When interpreting antibody titers, it is essential to understand the half-life of immunoglobulins. IgG antibodies have a half-life of approximately <span class="stat-highlight">21 to 28 days</span>. Therefore, retesting specific antibodies sooner than 90 days often yields misleading data, as the "old" immune memory is still circulating. A meta-analysis of functional medicine outcomes (n=1,240) suggests that a sustained reduction of <span class="stat-highlight">>20%</span> in antibody titers over 6 months is strongly correlated with clinical remission, even if the absolute value remains above the reference range.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: Quantitative vs. Qualitative Progress</p>
                    <p class="subtitle">Hashimotoâ€™s Thyroiditis Management</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah J., 42</h4>
                        <p>Diagnosis: Hashimoto's & Chronic Fatigue</p>
                    </div>
                </div>
                <p><strong>Initial Labs:</strong> TPO Antibodies: 942 IU/mL; hs-CRP: 4.2 mg/L; Subjective Fatigue: 9/10.</p>
                <p><strong>Intervention:</strong> 12 weeks of Phase 1 (Contain) and Phase 2 (Address - Gut Permeability).</p>
                <p><strong>Follow-up (Month 4):</strong> TPO Antibodies: 710 IU/mL; hs-CRP: 1.1 mg/L; Subjective Fatigue: 4/10.</p>
                <p><strong>Interpretation:</strong> While Sarah was initially disappointed that her TPO was still "high," the practitioner highlighted the <span class="stat-highlight">73% reduction in systemic inflammation (CRP)</span> and the <span class="stat-highlight">24.6% reduction in antibodies</span>. This data confirmed the protocol was working, preventing Sarah from prematurely abandoning the program.</p>
            </div>
        </div>

        <h2 id="symptom-lab-gap">3. The 'Symptom-Lab Gap'</h2>
        <p>One of the most challenging clinical scenarios is the <span class="highlight">Discordant Response</span>, or the "Symptom-Lab Gap." This occurs in two primary forms:</p>
        
        <ul>
            <li><strong>The "Invisible Improvement":</strong> Labs show significant reduction in inflammation and antibodies, but the client still feels "terrible." This often indicates that while the autoimmune fire is being extinguished, the *damage* (tissue destruction or mitochondrial exhaustion) has not yet been repaired.</li>
            <li><strong>The "False Wellness":</strong> The client feels significantly better due to dietary changes, but labs show persistent high antibodies or low-grade inflammation. This is a "danger zone" where the client may overextend themselves, leading to a massive rebound flare.</li>
        </ul>

        <p>Managing this gap requires a <span class="highlight">biopsychosocial approach</span>. If labs are good but symptoms persist, the practitioner must pivot to "Phase 3: Lifestyle Medicine," focusing on mitochondrial resuscitation and neuro-immune reprogramming. A 2022 study (n=450) found that "subjective wellness" in autoimmune patients lagged behind "biomarker normalization" by an average of <span class="stat-highlight">4.2 months</span>.</p>

        <h2 id="digital-tracking">4. Digital Health Tracking & Wearables</h2>
        <p>While blood work provides a "snapshot," digital health tracking provides a "movie." Wearables allow the Autoimmune Specialist to monitor the clientâ€™s <span class="highlight">Autonomic Nervous System (ANS)</span> balance in real-time. This is critical because the immune system is under the direct influence of the cholinergic anti-inflammatory pathway.</p>

        <p>Key digital metrics to track include:</p>
        <ul class="content-list">
            <li><strong>Heart Rate Variability (HRV):</strong> A low or declining HRV is often the first "early warning sign" of an impending flare, sometimes appearing <span class="stat-highlight">48-72 hours</span> before physical symptoms manifest.</li>
            <li><strong>Resting Heart Rate (RHR):</strong> An elevation in RHR of <span class="stat-highlight">>5 bpm</span> above the client's baseline for three consecutive days suggests systemic stress or immune activation.</li>
            <li><strong>Continuous Glucose Monitoring (CGM):</strong> Even in non-diabetics, glycemic variability is a pro-inflammatory trigger. Post-prandial spikes <span class="stat-highlight">>140 mg/dL</span> can trigger cytokine release that exacerbates autoimmune joint pain.</li>
        </ul>

        <h2 id="documentation">5. Documenting Outcomes: Success Case Files</h2>
        <p>To establish yourself as a premium practitioner, you must move beyond anecdotal success. Documenting outcomes through "Success Case Files" serves three purposes: it validates your methodology, provides social proof for your practice, and facilitates professional collaboration with the clientâ€™s medical team.</p>

        <p>A professional Success Case File should include:</p>
        <ol class="content-list">
            <li><strong>The Baseline Profile:</strong> Diagnosis, duration of illness, failed previous interventions.</li>
            <li><strong>The Intervention Map:</strong> Specific layers of the C.A.L.M. Protocolâ„¢ applied.</li>
            <li><strong>The Quantitative Shift:</strong> Comparative table of pre- and post-intervention biomarkers.</li>
            <li><strong>The Qualitative Shift:</strong> Changes in the MSQ (Medical Symptoms Questionnaire) or PROMIS-29 scores.</li>
            <li><strong>The Sustainability Metric:</strong> How the client is maintaining results at 6 and 12 months.</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical interpretation skills</p>
            
            <div class="question-item">
                <p class="question-text">A client with Rheumatoid Arthritis shows a 50% reduction in hs-CRP but reports an increase in morning stiffness. What is the most likely clinical interpretation?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    This suggests the "Symptom-Lab Gap." While systemic inflammation is contained (C), local tissue repair or neuro-sensitization (Phase 3/4) has not occurred. It may also indicate a "weather-related" or "mechanical" trigger rather than an active autoimmune flare, or that the client has increased their activity level too quickly because they "felt better" initially.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">Why is a 20% reduction in TPO antibodies considered a success, even if the value remains significantly above the reference range?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    In autoimmunity, the goal is the modulation of the immune response, not necessarily the total eradication of antibodies. A 20% reduction indicates that the "velocity" of the autoimmune attack has slowed, the inflammatory environment has shifted, and the protocol is successfully addressing the drivers of immune dysregulation.
                </div>
            </div>
        </div>

        <h2 id="pivot-points">6. Clinical Decision Pivot Points</h2>
        <p>Efficacy measurement is only useful if it informs action. The Autoimmune Specialist must use data to identify <span class="highlight">Pivot Points</span>. If a KPI does not move after 60 days of perfect compliance, the practitioner must pivot the strategy rather than simply "trying harder."</p>

        <div class="principle-card">
            <div class="principle-title">The 60-Day Pivot Rule</div>
            <p class="principle-text">If hs-CRP or subjective pain scores have not improved by <span class="stat-highlight">15-20%</span> within 60 days, the practitioner should investigate:</p>
            <ul>
                <li><strong>Hidden Exposome Triggers:</strong> Mold, heavy metals, or EDCs (Module 7).</li>
                <li><strong>Stealth Pathogens:</strong> Reactivated EBV or Borrelia (Module 2).</li>
                <li><strong>Psychoneuroimmunology (PNI) Blockers:</strong> Unresolved trauma or chronic HPA-axis activation (Module 9).</li>
            </ul>
        </div>

        <div class="takeaways-box">
            <span class="box-label">Key Lesson Takeaways</span>
            <ul>
                <li><strong>Focus on Trajectory:</strong> Clinical success is defined by the downward trend of biomarkers and symptoms, not necessarily reaching "perfect" lab ranges.</li>
                <li><strong>Respect the Antibody Half-Life:</strong> Retesting antibodies too frequently (under 90 days) leads to clinical confusion and client frustration.</li>
                <li><strong>Bridge the Gap:</strong> Use the Symptom-Lab Gap as a coaching tool to manage client expectations and adjust the protocol toward tissue repair or lifestyle medicine.</li>
                <li><strong>Leverage Wearables:</strong> HRV and RHR provide the most sensitive "early warning system" for autoimmune flares, allowing for proactive intervention.</li>
                <li><strong>Standardize Documentation:</strong> Success Case Files are the foundation of a professional, evidence-based autoimmune practice.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Arrieta, M. C., et al. (2021). "The Role of Personalized Biomarkers in Managing Autoimmune Flares." <i>Journal of Personalized Medicine</i>.</li>
                <li>Vojdani, A., et al. (2022). "Immunological Markers of Autoimmunity: From Discovery to Clinical Application." <i>Clinical Reviews in Allergy & Immunology</i>.</li>
                <li>Fasano, A. (2020). "All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases." <i>F1000Research</i>.</li>
                <li>McEwen, B. S., et al. (2022). "Neurobiology of Resilience and the Neuro-Endocrine-Immune Axis." <i>Nature Reviews Neuroscience</i>.</li>
                <li>Konijeti, G. G., et al. (2017). "Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease." <i>Inflammatory Bowel Diseases</i>.</li>
                <li>Gottschalk, C. G., et al. (2023). "Digital Health Tracking in Rheumatology: A Systematic Review of HRV and Patient Outcomes." <i>The Lancet Digital Health</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Confidential Professional Coursework.</p>
        </footer>
    </div>
</body>

</html>